Inventor
CHRISTOPHER G. NASVESCHUK
Inventor
US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes23%
Y02ATechnologies for adaptation to climate change5%
G07FCoin-freed or like apparatus4%
C07JSteroids3%
C07KPeptides1%
PatentTitleYear
12,570,626Degraders and degrons for targeted protein degradation202612,559,492BRAF degraders202612,528,797Heterocyclic compounds for medical treatment202612,486,253Therapeutics for the degradation of mutant BRAF202512,486,290Isoindolinone and indazole compounds for the degradation of EGFR202512,454,521Targeted protein degradation202512,441,740N/O-linked degrons and degronimers for protein degradation202512,421,220Bicyclic-substituted glutarimide cereblon binders202512,371,442Isoindolinone and indazole compounds for the degradation of EGFR202512,227,504Spirocyclic compounds202512,180,225N/O-linked degrons and degronimers for protein degradation202412,157,735Compounds for targeted degradation of BRD9202412,076,405Heterocyclic degronimers for target protein degradation202412,048,748Spirocyclic degronimers for target protein degradation202412,049,464Compounds for targeted degradation of BRD9202412,048,747Substituted piperidine Degronimers for Target Protein degradation202411,992,531C202411,753,397Cereblon binders for the degradation of ikaros202311,691,972Compounds for targeted degradation of BRD9202311,673,902Isoindolinone and indazole compounds for the degradation of EGFR202311,623,929Spirocyclic compounds202311,584,748Spirocyclic compounds202311,524,949Degraders and Degrons for targeted protein degradation202211,459,335N/O-linked Degrons and Degronimers for protein degradation202211,185,592Spirocyclic degronimers for target protein degradation2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to C4 THERAPEUTICS INC (25)· patent assignee history
2021–2026Based in US· patent location history
2025Patents assigned to C4 THEREPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| C4 THERAPEUTICS INC | 25 | 2021–2026 |
| C4 THEREPEUTICS INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 25 | 2021–2026 |